Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada-Reference-Cited by-同舟云学术

Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada

Published:2021-07 Issue: Volume:151 Page:126-135
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Gupta Sumit,Sutradhar Rinku,Li Qing,Athale Uma,Bassal Mylene,Breakey Vicky,Gibson Paul J.,Patel Serina,Silva Mariana,Zabih Veda,Pechlivanoglou Petros,Pole Jason D.,Mittmann Nicole

Funder

C17 Council

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Acute lymphoblastic leukemia in children;Hunger;N Engl J Med,2015

2. Impact of intrathecal triple therapy versus intrathecal methotrexate on disease-free survival for high-risk B-lymphoblastic leukemia: Children's Oncology Group Study AALL1131;Salzer;J Clin Oncol,2020

3. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial;Place;Lancet Oncol,2015

4. Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude Total Therapy Study 16;Jeha;J Clin Oncol,2019

5. Cost-effectiveness of treatment of childhood acute lymphoblastic leukemia with chemotherapy only: the influence of new medication and diagnostic technology;van Litsenburg;Pediatr Blood Canc,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthcare costs of cancer among children, adolescents, and young adults: A scoping review;Cancer Medicine;2024-01-12

2. The Role of miRNAs in Childhood Acute Lymphoblastic Leukemia Relapse and the Associated Molecular Mechanisms;International Journal of Molecular Sciences;2023-12-21

3. Estimating the Associated Burden of Illness and Healthcare Utilization of Newly Diagnosed Patients Aged ≥65 with Mantle Cell Lymphoma (MCL) in Ontario, Canada;Current Oncology;2023-06-08

4. Real-World Cost of Pediatric Acute Lymphoblastic Leukemia Care Among Commercially Insured Individuals in the United States: Effect of Era and Age at Diagnosis;JCO Oncology Practice;2022-11

5. Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma;Frontiers in Pediatrics;2022-06-30